The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study
Open accessAbstract
BACKGROUND: The feasibility and clinical implication of drug monitoring of morphine, morphine-6-glucuronide (M6G) and morphine-3-glucuronide (M3G) need further investigation. This study aimed to determine what predicts serum concentrations of morphine in cancer patients receiving continuously intravenous morphine, the relationships between serum concentration of morphine/its metabolites and urinary concentrations, and the relation between morphine concentrations and with clinical outcomes. METHODS: We collected serum and urine samples from 24 patients with advanced cancer undergoing continuously intravenous morphine therapy. Serum samples were obtained at day one. Spot urine samples were collected once daily on three consecutive days. Pain and adverse drug events were assessed using the Korean version of MD Anderson Symptom Inventory. RESULTS: A total of 96 samples (72 urine and 24 serum samples) were collected. Median dose of morphine was 82.0 mg/24 h. In a multivariate analysis, total daily morphine dose was the most significant predictors of both serum and urine concentration of morphine. Morphine, M6G, and M3G in serum and urine were statistical significantly correlated (correlation coefficient = 0.81, 0.44, 0.56; p values < 0.01, 0.03, 0.01, respectively). CONCLUSION: Spot urine concentrations of morphine and its metabolites were highly correlated to those of serum. Total dose of daily morphine was related to both serum and urine concentration of morphine and its metabolites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, S. S., Hutchinson, M. R., Rezvani, N., Loram, L. C., Zhang, Y., Maier, S. F., Rice, K. C., & Watkins, L. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.011 · Cited by 184
Urine Drug Testing In Chronic Pain
Christo, P. J. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/123 · Cited by 184
Systematic review of factors affecting the ratios of morphine and its major metabolites
Faura, C. C., Collins, S. L., Moore, A. R., & McQuay, H. J. (1998) · Pain · doi:10.1016/s0304-3959(97)00142-5 · Cited by 165
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients
Tiseo, P. J., Thaler, H. T., Lapin, J., et al. (1995) · Pain · doi:10.1016/0304-3959(94)00148-8 · Cited by 148
Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients
Ashby, M., Fleming, B. G., Wood, M., et al. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00020-1 · Cited by 98
Monitoring Opioid Adherence in Chronic Pain Patients: Tools, Techniques, and Utility
Manchikanti, L., Atluri, S., Trescot, A. M., & Giordano, J. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s155 · Cited by 98
Sjøgren, P., Thunedborg, L. P., Christrup, L. L., Hansen, S. H., & Franks, J. (1998) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1998.tb05378.x · Cited by 94
Darke, S. G., Sunjic, S., ZADOR, D. A., et al. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00070-7 · Cited by 92
Klepstad, P., Kaasa, S., & Borchgrevink, P. C. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050003 · Cited by 88
Self-citationKlepstad, P., Borchgrevink, P. C., Dale, O., Zahlsen, K., Aamo, T. O., Fayers, P. M., Fougner, B., & Kaasa, S. (2003) · Palliative Medicine · doi:10.1191/0269216303pm835oa · Cited by 58
Self-citation
Cited by
Nitazenes: review of comparative pharmacology and antagonist action
Stangeland, M., Dale, O., & Skulberg, A. K. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2504133 · Cited by 34
Metadata
- Authors
- Lee, Y. J., Suh, S.-Y., Song, J., Lee, S. S., Seo, A.-R., Ahn, H.-Y., Lee, M. A., Kim, C.-M., & Klepstad, P.
- Affiliations
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Dongguk University (KR)
- Seoul National University (KR)
- Norwegian University of Science and Technology (NO)
- Corresponding author
- Suh, Sang-Yeon
- Venue
- BMC Palliative Care
- Published
- 2015-10-27
- Volume
- 14
- Issue
- 1
- Pages
- 53-53
- ISSN
- 1472-684X (ISSN-L)
- PMC
- PMC4624671
- OpenAlex
- W1878898226
- Cited by
- 14
- References
- 17
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Palliative Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- morphine, morphine-6-glucuronide, morphine-3-glucuronide, morphine metabolites, drug monitoring, advanced cancer, serum concentration, pain, adverse drug reactions, opioid pharmacokinetics
- MeSH terms
- Adult, Aged, Aged, 80 and over, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Morphine, Morphine Derivatives, Neoplasms, Drug Monitoring, Republic of Korea, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study. https://app.cochat.ai/papers/10.1186/s12904-015-0052-9
- The paper
- Lee, Y. J., Suh, S.-Y., Song, J., Lee, S. S., Seo, A.-R., Ahn, H.-Y., Lee, M. A., Kim, C.-M., & Klepstad, P. (2015). Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study. BMC Palliative Care. https://doi.org/10.1186/s12904-015-0052-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.